SIGYN THERAPEUTICS, INC. Unamortized Debt Issuance Expense
SIGYN THERAPEUTICS, INC. (SIGY) had Unamortized Debt Issuance Expense of $421.24 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2023-08-14
- 2023-06-30: Unamortized Debt Issuance Expense $421.24K.
- 2023-03-31: Unamortized Debt Issuance Expense $778.41K.
- 2022-12-31: Unamortized Debt Issuance Expense $642.66K.
- 2022-09-30: Unamortized Debt Issuance Expense $406.37K.
| Period end | Unamortized Debt Issuance Expense | Unamortized Debt Issuance Expense as first filed |
|---|---|---|
| 2023-06-30 | $421.24K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $778.41K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $642.66K 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $406.37K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $333.10K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $215.90K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $53.61K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $46.76K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $105.20K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $258.25K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $97.83K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $0.00 10-K · filed 2021-04-06 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $9.25K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $18.50K 10-Q · filed 2019-04-19 | |
| 2018-12-31 | $70.00K 10-K · filed 2020-03-30 | $27.75K 10-K · filed 2019-04-01 |
| 2017-12-31 | $70.00K 10-K · filed 2019-04-01 |